Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | ACLY | P53396 | 3/20 | 0.54 |
| ▸ | IKBKB | O14920 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CCR2 | P41597 | 2/20 | 0.47 |
| ▸ | CCR1 | P32246 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3816575 | 0.92 | NPSR1 (0.67) | NPSR1KDM4ERXFP1ACLYIKBKB | |
| SCHEMBL3809012 | 0.90 | NPSR1 (0.56) | NPSR1KDM4ERXFP1ACLYCCR2 | |
| SCHEMBL3811715 | 0.89 | NPSR1 (0.69) | NPSR1KDM4ERXFP1IKBKBMEN1 | |
| SCHEMBL3809896 | 0.89 | ACLY (0.53) | NPSR1KDM4ERXFP1ACLYALDH1A1 | |
| SCHEMBL3809449 | 0.89 | ACLY (0.55) | NPSR1KDM4ERXFP1ACLYIKBKB | |
| SCHEMBL3810994 | 0.89 | NPSR1 (0.55) | NPSR1KDM4ERXFP1ACLYIKBKB | |
| SCHEMBL3807620 | 0.88 | NPSR1 (0.57) | NPSR1KDM4ERXFP1IKBKB | |
| SCHEMBL3811534 | 0.88 | ACLY (0.52) | NPSR1KDM4ERXFP1ACLYIKBKB | |
| SCHEMBL3815310 | 0.87 | NPSR1 (0.62) | NPSR1KDM4ERXFP1ACLYIKBKB | |
| SCHEMBL3814654 | 0.87 | ACLY (0.51) | NPSR1KDM4ERXFP1ACLYALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1401825-B1 | THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS FOR FLAVIVIRUS INFECTION | VIROCHEM PHARMA INC (CA) | 2009-08-05 | — | — | EP | claimed |